DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)
TARS
TARSUS PHARMACEUTICALS INC
266 institutions still hold TARSUS PHARMACEUTICALS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 87650L103·Biological Products, (No Diagnostic Substances)·266 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
266 institutions reported TARS in Q1 2026. Deep Track Capital, LP leads at 11.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 14
246 more holders available. Log in →